Mga Batayang Estadistika
| LEI | 549300WT8EMZSV1XVW72 |
| CIK | 1604522 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Abrdn Healthcare Opportunities Fund
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| October 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| October 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| October 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 27, 2023 |
BY-LAWS TEKLA HEALTHCARE OPPORTUNITIES FUND Revised through June 8, 2023 ARTICLE I Exhibit (b) BY-LAWS OF TEKLA HEALTHCARE OPPORTUNITIES FUND Revised through June 8, 2023 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Declaration of Trust of Tekla Healthcare Opportunities Fund dated April 2, 2014 as amended from time to time. |
|
| September 27, 2023 |
As filed with the Securities and Exchange Commission on September 27, 2023 As filed with the Securities and Exchange Commission on September 27, 2023 Securities Act File No. |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 12, 2023 |
Exhibit 16.1 September 12, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Tekla Healthcare Opportunities Fund's Form 8-K dated September 12, 2023, and we agree with the statements made therein. Yours truly, Deloitte & Touche LLP 200 Berkeley Street Boston, MA 02116 USA Tel: 617-437-2625 Fax: 617-437-4625 www.deloit |
|
| September 12, 2023 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2023 (September 6, 2023) Tekla Healthcare Opportunities Fund (Exact name of Registrant as Specified in Its Charter) Massachusetts 811-22955 46-5317248 (State or other ju |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 22, 2023 |
Tekla Healthcare Investors Tekla Life Sciences Investors Tekla Healthcare Opportunities Fund Tekla World Healthcare Fund August 22, 2023 Via EDGAR Mindy Rotter U. |
|
| August 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| April 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| July 29, 2022 |
As filed with the Securities and Exchange Commission on July 29, 2022 As filed with the Securities and Exchange Commission on July 29, 2022 Securities Act File No. |
|
| July 29, 2022 |
TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee Exhibit (a)(ix) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, upon the death of Oleg M. |
|
| July 1, 2022 |
Notice of Change of Trustee, filed herewith Exhibit (a)(viii) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla Healthcare Opportunities Fund (the ?Fund?), the Trustees of the Fund appointed W. |
|
| July 1, 2022 |
As filed with the Securities and Exchange Commission on July 1, 2022 As filed with the Securities and Exchange Commission on July 1, 2022 Securities Act File No. |
|
| July 1, 2022 |
Power of Attorney dated June 9, 2022, filed herewith Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that W. Mark Watson, whose signature appears below, constitutes and appoints Daniel R. Omstead, Laura Woodward, Christopher Harvey and Kaitlin McGrath and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution among himself or herself and each of the persons appointed herein, for him |
|
| April 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| February 23, 2022 |
Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS December 31, 2021 Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS December 31, 2021 (Unaudited) SHARES CONVERTIBLE PREFERRED (Restricted) (a) (b) - 0. |
|
| December 22, 2021 |
Power of Attorney dated November 30, 2021, (12) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Kathleen L. |
|
| December 22, 2021 |
Notice of Change of Trustee, dated December 22, 2021 (14) Exhibit (a)(vii) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla Healthcare Opportunities Fund (?The Fund?), the Trustees of the Fund appointed Kathleen L. |
|
| December 22, 2021 |
As filed with the Securities and Exchange Commission on December 22, 2021 As filed with the Securities and Exchange Commission on December 22, 2021 Securities Act File No. |
|
| August 26, 2021 |
Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS June 30, 2021 Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS June 30, 2021 (Unaudited) SHARES CONVERTIBLE PREFERRED (Restricted)(a)(b) - 1. |
|
| July 2, 2021 |
As filed with the Securities and Exchange Commission on July 2, 2021 As filed with the Securities and Exchange Commission on July 2, 2021 Securities Act File No. |
|
| July 2, 2021 |
Notice of Change of Trustee dated June 16, 2021(11) Exhibit (a)(vi) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Lucinda H. |
|
| April 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 26, 2021 |
Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS December 31, 2020 Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS December 31, 2020 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS (Restricted)(a) (b) - 1. |
|
| January 5, 2021 |
By-Laws of the Registrant, as amended(10) Exhibit (b) BY-LAWS OF TEKLA HEALTHCARE OPPORTUNITIES FUND Revised through December 10, 2020 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Declaration of Trust of Tekla Healthcare Opportunities Fund dated April 2, 2014 as amended from time to time. |
|
| January 5, 2021 |
As filed with the Securities and Exchange Commission on January 5, 2020 Securities Act File No. |
|
| September 10, 2020 |
Power of Attorney dated August 27, 2020(9) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Jeffrey A. |
|
| September 10, 2020 |
Notice of Change of Trustee dated August 27, 2020(9) Exhibit (a)(v) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla Healthcare Opportunities Fund (“The Fund”), the Trustees of the Fund appointed Jeffrey A. |
|
| September 10, 2020 |
As filed with the Securities and Exchange Commission on September 10, 2020 Securities Act File No. |
|
| August 25, 2020 |
Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS June 30, 2020 Tekla Healthcare Opportunities Fund SCHEDULE OF INVESTMENTS June 30, 2020 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS (Restricted)(a) (b) - 1. |
|
| May 8, 2020 |
Tekla Healthcare Investors Tekla Life Sciences Investors 100 Federal Street, 19th Floor Tekla Healthcare Opportunities Fund Boston, Massachusetts 02110 Tekla World Healthcare Fund Tel: (617) 772-8500 May 8, 2020 Via EDGAR Jeff Long U. |
|
| April 14, 2020 |
HQH / Tekla Healthcare Investors DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 27, 2020 |
TEKLA HEALTHCARE OPPORTUNITIES FUND SCHEDULE OF INVESTMENTS DECEMBER 31, 2019 TEKLA HEALTHCARE OPPORTUNITIES FUND SCHEDULE OF INVESTMENTS DECEMBER 31, 2019 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS (Restricted)(a) (b) - 0. |
|
| August 29, 2019 |
THQ / Tekla Healthcare Opportunies Fund NPORT-EX - - TEKLA HEALTHCARE OPPORTUNITIES FUND SCHEDULE OF INVESTMENTS JUNE 30, 2019 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS (Restricted)(a) (b) - 1. |
|
| June 20, 2019 |
As filed with the Securities and Exchange Commission on June 20, 2019 Securities Act File No. |
|
| June 20, 2019 |
Notice of Change of Trustee dated June 13, 2019(7) Exhibit (a)(iv) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Elizabeth G. |
|
| April 15, 2019 |
HQH / Tekla Healthcare Investors DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 12, 2019 |
Power of Attorney dated December 13, 2018(6) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Elizabeth G. |
|
| March 12, 2019 |
Notice of Change of Trustee dated December 13, 2018(6) Exhibit (a)(iii) TEKLA HEALTHCARE OPPORTUNITES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Michael Bonney tendered his resignation as a Trustee of Tekla Healthcare Opportunities Fund (the “Fund”) effective November 1, 2018, the Fund issues this notice in accordance with the terms of the Declaration of Trust of the Fund, dated April 2, 2014 and filed with the Secretary of State of the Commonwealth of Massachusetts on April 3, 2014, as amended; WHEREAS, at a meeting of the Trustees of Tekla Healthcare Opportunities Fund (“The Fund”) on December 13, 2018, the Trustees of the Fund appointed Dr. |
|
| March 12, 2019 |
THQ / Tekla Healthcare Opportunies Fund POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS As filed with the Securities and Exchange Commission on March 12, 2019 Securities Act File No. |
|
| February 26, 2019 |
Tekla Healthcare Opportunities Fund - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| February 26, 2019 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| August 28, 2018 |
THQ / Tekla Healthcare Opportunies Fund N-Q (Quarterly Schedule of Portfolio Holdings) N-Q 1 a18-152593nq.htm N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . . . . . . . . . . 10.5 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-22955 Tekla Healthcare Opportunities Fun |
|
| August 28, 2018 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| April 18, 2018 |
HQH / Tekla Healthcare Investors DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 18, 2018 |
Notice of Change of Trustee dated December 20, 2017(5) Exhibit (a)(ii) TEKLA HEALTHCARE OPPORTUNITIES FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, upon the death of Uwe E. |
|
| April 18, 2018 |
THQ / Tekla Healthcare Opportunies Fund POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS As filed with the Securities and Exchange Commission on April 18, 2018 Securities Act File No. |
|
| April 18, 2018 |
Power of Attorney dated April 9, 2018(5) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Thomas M. |
|
| April 18, 2018 |
By-Laws of the Registrant, as amended (5) Exhibit (b) BY-LAWS OF TEKLA HEALTHCARE OPPORTUNITIES FUND Revised through April 4, 2018 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Declaration of Trust of Tekla Healthcare Opportunities Fund dated April 2, 2014 as amended from time to time. |
|
| April 18, 2018 |
Exhibit (k)(vi) Destra Capital Management LLC One North Wacker Drive 48th Floor Chicago, Illinois 60606 April 2, 2018 VIA EMAIL Tekla Funds 100 Federal Street, 19th Floor Boston, MA 02110 Re: Assignment/Written Consent Dear Laura Woodward: Due to an internal business matter, the management at Destra Capital Management LLC (“DCM”), the parent company of Destra Capital Investments LLC (“Destra”), ha |
|
| February 23, 2018 |
Tekla Healthcare Opportunities Fund - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| February 23, 2018 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| August 25, 2017 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| August 25, 2017 |
Tekla Healthcare Opportunities Fund - N-Q N-Q 1 a17-185963nq.htm N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . . . . . . . . . . 10.5 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-22955 Tekla Healthcare Opportunities Fun |
|
| July 18, 2017 |
Tekla Healthcare Investors ESP Tekla Healthcare Investors 100 Federal Street, 19th Floor Tekla Life Sciences Investors Boston, Massachusetts 02110 Tekla Healthcare Opportunities Fund Tel: (617) 772-8500 July 18, 2017 VIA EDGAR Kathy Churko U. |
|
| June 19, 2017 |
Tekla Healthcare Investors ESP Tekla Healthcare Investors Tekla Life Sciences Investors 100 Federal Street, 19th Floor Tekla Healthcare Opportunities Fund Boston, Massachusetts 02110 Tel: (617) 772-8500 June 19, 2017 VIA EDGAR Kathy Churko U. |
|
| June 19, 2017 |
Exhibit (k)(v) SUPPORT SERVICES AGREEMENT This Agreement is made as of January 1, 2016, by and among Tekla World Healthcare Fund, Tekla Healthcare Opportunities Fund, Tekla Healthcare Investors and Tekla Life Sciences Investors, Massachusetts business trusts (together, the ?Tekla Funds? or the ?Funds?), and Destra Capital Investments LLC, a Delaware limited liability company (?Destra?). |
|
| June 19, 2017 |
As filed with the Securities and Exchange Commission on June 19, 2017 As filed with the Securities and Exchange Commission on June 19, 2017 Securities Act File No. |
|
| April 18, 2017 |
Tekla Healthcare Investors PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 24, 2017 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| February 24, 2017 |
Tekla Healthcare Opportunities Fund - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| August 26, 2016 |
Tekla Healthcare Opportunities Fund - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| August 26, 2016 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| April 18, 2016 |
Tekla Healthcare Investors ESP One International Place, 40th Floor 100 Oliver Street Boston, MA 02110-2605 +1 617 728 7100 Main +1 617 426 6567 Fax www. |
|
| April 18, 2016 |
Tekla Healthcare Investors DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 4, 2016 |
Tekla Life Sciences Investors PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| February 26, 2016 |
Tekla Healthcare Opportunities Fund - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 UNITED STATES Estimated average burden hours per response . |
|
| February 26, 2016 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| August 27, 2015 |
Tekla Healthcare Opportunities Fund - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 UNITED STATES Estimated average burden hours per response . |
|
| August 27, 2015 |
EX-99.CERT 2 a15-171713ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstance |
|
| April 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 26, 2015 |
Tekla Healthcare Opportunities Fund - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-22955 Tekla Healthcare Opportunities Fund (Exact name of registrant as specifi |
|
| February 26, 2015 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Opportunities Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mis |
|
| July 28, 2014 |
Opinion and Consent of Dechert LLP(4) Exhibit 99.(l) One International Place, 40th Floor 100 Oliver Street Boston, MA 02110 +1 617 728 7100 Main +1 617 426 6567 Fax www.dechert.com July 28, 2014 Tekla Healthcare Opportunities Fund 2 Liberty Square, 9th Floor Boston, MA 02109 Re: Registration Statement on Form N-2 Ladies and Gentlemen: We have acted as counsel to Tekla Healthcare Opportunities Fund, a Massachusetts business trust (the |
|
| July 28, 2014 |
THQ / Tekla Healthcare Opportunies Fund N-2MEF - - N-2MEF As filed with the Securities and Exchange Commission on July 28, 2014 Securities Act File No. |
|
| July 28, 2014 |
Consent of Deloitte & Touche LLP(4) Exhibit 99.(n) CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form N-2 filed pursuant to Rule 462(b) of our report dated June 23, 2014, relating to the statement of assets and liabilities of Tekla Healthcare Opportunities Fund as of June 2, 2014, and to the reference to us under the heading “Independent Regist |
|
| July 25, 2014 |
THQ / Tekla Healthcare Opportunies Fund CORRESP - - TEKLA HEALTHCARE OPPORTUNITIES FUND 2 Liberty Square, 9th Floor Boston, MA 02109 VIA EDGAR July 25, 2014 Catherine Courtney Gordon Senior Counsel Division of Investment Management Securities and Exchange Commission 100 F Street, N. |
|
| July 21, 2014 |
THQ / Tekla Healthcare Opportunies Fund 8-A12B - - 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 TEKLA HEALTHCARE OPPORTUNITIES FUND (Exact name of Registrant as specified in Charter) Massachusetts 46-5317248. (State of incorporation or organization) (IRS Employer Identification No.) 2 Liberty |
|
| June 25, 2014 |
One International Place, 40th Floor 100 Oliver Street Boston, MA 02110 +1 617 728 7100 Main +1 617 275 8405 Fax www. |
|
| June 9, 2014 |
CORRESP 1 filename1.htm One International Place, 40th Floor 100 Oliver Street Boston, MA 02110 +1 617 728 7100 Main +1 617 275 8405 Fax www.dechert.com JOSEPH R. FLEMING [email protected] +1 617 728 7161 Direct +1 617 275 8392 Fax June 9, 2014 Catherine C. Gordon Senior Counsel Division of Investment Management Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-0 |
|
| April 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-8A NOTIFICATION OF REGISTRATION FILED PURSUANT TO SECTION 8(a) OF THE INVESTMENT COMPANY ACT OF 1940 The undersigned investment company hereby notifies the Securities and Exchange Commission that it registers under and pursuant to the provisions of Section 8(a) of the Investment Company Act of 1940 and in connection wit |
